aluminum sulfate has been researched along with Dengue in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Collard, A; De La Barrera, R; Eckels, KH; Innis, BL; Jarman, RG; Lepine, E; Lin, L; Martinez, LJ; Paolino, KM; Ruck, RC; Schmidt, AC; Thomas, SJ; Toussaint, JF | 1 |
| Álvarez, M; Ambala, P; Gil, L; Guillén, G; Guzmán, MG; Hermida, L; Hitler, R; Izquierdo, A; Kariuki, T; Kimiti, P; Lazo, L; Marcos, E; Ndung'u, J; Ochola, L; Suzarte, E; Valdés, I | 1 |
| Preet, S; Sneha, A | 1 |
| Kochel, TJ; Maves, RC; Oré, RM; Porter, KR | 1 |
| Blanco, A; Gil, L; Guillén, G; Guzmán, MG; Hermida, L; Lazo, L; López, C; Pavón, A; Romero, Y; Valdés, I | 1 |
1 trial(s) available for aluminum sulfate and Dengue
| Article | Year |
|---|---|
Phase 1 Randomized Study of a Tetravalent Dengue Purified Inactivated Vaccine in Healthy Adults in the United States.
Topics: Adjuvants, Immunologic; Adolescent; Adult; Alum Compounds; Antibodies, Viral; Dengue; Dengue Vaccines; Dengue Virus; Dose-Response Relationship, Drug; Female; Humans; Male; Single-Blind Method; United States; Vaccination; Vaccines, Inactivated; Young Adult | 2017 |
4 other study(ies) available for aluminum sulfate and Dengue
| Article | Year |
|---|---|
The protein DIIIC-2, aggregated with a specific oligodeoxynucleotide and adjuvanted in alum, protects mice and monkeys against DENV-2.
Topics: Adjuvants, Immunologic; Alum Compounds; Animals; Antibodies, Neutralizing; Antibodies, Viral; Capsid Proteins; Chlorocebus aethiops; Dengue; Dengue Vaccines; Dengue Virus; Female; Flocculation; Gene Expression; Immunity, Cellular; Immunity, Humoral; Immunization; Mice; Mice, Inbred BALB C; Neutralization Tests; Oligodeoxyribonucleotides; Protein Binding; Recombinant Fusion Proteins; Viral Envelope Proteins | 2015 |
Biochemical evidence of efficacy of potash alum for the control of dengue vector Aedes aegypti (Linnaeus).
Topics: Adjuvants, Immunologic; Aedes; Alum Compounds; Animals; Complex Mixtures; Dengue; Humans; Insect Vectors; Insecticides; Larva; Mosquito Control | 2011 |
Immunogenicity and protective efficacy of a psoralen-inactivated dengue-1 virus vaccine candidate in Aotus nancymaae monkeys.
Topics: Adjuvants, Immunologic; Alum Compounds; Animals; Antibodies, Neutralizing; Antibodies, Viral; Aotidae; Dengue; Dengue Vaccines; Dengue Virus; Disinfectants; Ficusin; Immunization, Secondary; Immunoglobulin G; Immunoglobulin M; Time Factors; Vaccination; Viremia; Virus Inactivation | 2011 |
A vaccine formulation consisting of nucleocapsid-like particles from Dengue-2 and the fusion protein P64k-domain III from Dengue-1 induces a protective immune response against the homologous serotypes in mice.
Topics: Adjuvants, Immunologic; Alum Compounds; Animals; Antibodies, Neutralizing; Antibodies, Viral; Capsid Proteins; Dengue; Dengue Vaccines; Dengue Virus; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Female; Interferon-gamma; Leukocytes, Mononuclear; Mice; Mice, Inbred BALB C; Neutralization Tests; Survival Analysis; Vaccines, Synthetic; Vaccines, Virus-Like Particle; Viral Fusion Proteins | 2012 |